140 related articles for article (PubMed ID: 3208866)
1. Application of megakaryocytic morphology in diagnosing 5q- syndrome.
Thiede T; Engquist L; Billström R
Eur J Haematol; 1988 Nov; 41(5):434-7. PubMed ID: 3208866
[TBL] [Abstract][Full Text] [Related]
2. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
3. Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
Lewis S; Oscier D; Boultwood J; Ross F; Fitchett M; Rack K; Abrahamson G; Buckle V; Wainscoat JS
Am J Hematol; 1995 Jul; 49(3):194-200. PubMed ID: 7604812
[TBL] [Abstract][Full Text] [Related]
4. Myeloid disorders with deletion of 5q as the sole karyotypic abnormality: the clinical and pathologic spectrum.
Washington LT; Doherty D; Glassman A; Martins J; Ibrahim S; Lai R
Leuk Lymphoma; 2002 Apr; 43(4):761-5. PubMed ID: 12153162
[TBL] [Abstract][Full Text] [Related]
5. A prognostic impact of separation of refractory cytopenia with multilineage dysplasia and 5q- syndrome from refractory anemia in primary myelodysplastic syndrome.
Cermák J; Michalová K; Brezinová J; Zemanová Z
Leuk Res; 2003 Mar; 27(3):221-9. PubMed ID: 12537974
[TBL] [Abstract][Full Text] [Related]
6. Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes.
Stewart B; Verdugo M; Guthrie KA; Appelbaum F; Deeg HJ
Br J Haematol; 2003 Dec; 123(5):879-85. PubMed ID: 14632779
[TBL] [Abstract][Full Text] [Related]
7. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome.
Suciu S; Kuse R; Weh HJ; Hossfeld DK
Cancer Genet Cytogenet; 1990 Jan; 44(1):15-26. PubMed ID: 2293879
[TBL] [Abstract][Full Text] [Related]
8. 5q- in a child with refractory anemia with excess blasts: similarities to 5q- syndrome in adults.
Antillón F; Raimondi SC; Fairman J; Liang H; Nagarajan L; Head D; Ribeiro RC
Cancer Genet Cytogenet; 1998 Sep; 105(2):119-22. PubMed ID: 9723027
[TBL] [Abstract][Full Text] [Related]
9. Leukemic transformation in patients with 5Q- and additional abnormalities.
Larripa I; Acevedo S; Palau Nagore MV; Bengiò R; Mondini N; Slavutsky I
Haematologica; 1991; 76(5):363-7. PubMed ID: 1806438
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes.
Solé F; Prieto F; Badia L; Woessner S; Florensa L; Caballin MR; Coll MD; Besses C; Sans-Sabrafen J
Cancer Genet Cytogenet; 1992 Nov; 64(1):12-20. PubMed ID: 1458444
[TBL] [Abstract][Full Text] [Related]
11. Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance.
Werner M; Maschek H; Kaloutsi V; Choritz H; Georgii A
Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):47-52. PubMed ID: 1636249
[TBL] [Abstract][Full Text] [Related]
12. Deletion of 5q31 is observed in megakaryocytic cells in patients with myelodysplastic syndromes and a del(5q), including the 5q- syndrome.
Godon C; Talmant P; Garand R; Accart F; Bataille R; Avet-Loiseau H
Genes Chromosomes Cancer; 2000 Dec; 29(4):350-2. PubMed ID: 11066080
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic profile of Indian patients with de novo myelodysplastic syndromes.
Chaubey R; Sazawal S; Dada R; Mahapatra M; Saxena R
Indian J Med Res; 2011 Oct; 134(4):452-7. PubMed ID: 22089606
[TBL] [Abstract][Full Text] [Related]
14. Specificity of haematological indicators for '5q- syndrome' in patients with myelodysplastic syndromes.
Teerenhovi L
Eur J Haematol; 1987 Oct; 39(4):326-30. PubMed ID: 3691757
[TBL] [Abstract][Full Text] [Related]
15. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.
Knipp S; Strupp C; Gattermann N; Hildebrandt B; Schapira M; Giagounidis A; Aul C; Haas R; Germing U
Leuk Res; 2008 Jan; 32(1):33-7. PubMed ID: 17412418
[TBL] [Abstract][Full Text] [Related]
16. [Myelodysplastic syndromes: current diagnosis and classification].
Tsvetaeva NV; Zavadenko MA; Ol'shanskaia IuV; Glasko EN; Khoroshko ND
Ter Arkh; 2001; 73(4):62-6. PubMed ID: 11494452
[No Abstract] [Full Text] [Related]
17. Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome.
Jaju RJ; Jones M; Boultwood J; Kelly S; Mason DY; Wainscoat JS; Kearney L
Genes Chromosomes Cancer; 2000 Nov; 29(3):276-80. PubMed ID: 10992302
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the 5q- chromosome.
Nagarajan L
Leuk Lymphoma; 1995 May; 17(5-6):361-6. PubMed ID: 7549826
[TBL] [Abstract][Full Text] [Related]
19. Correlations between cytogenetics and morphology in myelodysplastic syndromes.
Vila L; Charrin C; Archimbaud E; Treille-Ritouet D; Fraisse J; Felman P; Fiere D; Germain D
Blut; 1990 Apr; 60(4):223-7. PubMed ID: 2337681
[TBL] [Abstract][Full Text] [Related]
20. Re-evaluation of refractory anemia with excess blasts in transformation.
Ohyashiki K; Nishimaki J; Shoji N; Miyazawa K; Kimura Y; Ohyashiki JH
Leuk Res; 2001 Nov; 25(11):933-9. PubMed ID: 11597728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]